FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Global Health IPO and Kaynes Technology IPO.
Global Health IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Kaynes Technology IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Global Health IPO | Kaynes Technology IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Credit Suisse Securities (India) Private Limited Jefferies India Private Limited Jm Financial Limited |
Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Iifl Securities Ltd |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Global Health IPO is up to ₹2,205.57 Cr whereas the issue size of the Kaynes Technology IPO is up to ₹857.82 Cr. The final issue price of Global Health IPO is ₹336.00 per share and of Kaynes Technology IPO is ₹587.00 per share.
Global Health IPO | Kaynes Technology IPO | |
---|---|---|
Face Value | ₹2 per share | ₹10 per share |
Issue Price (Lower) | ₹319.00 per share | ₹559.00 per share |
Issue Price (Upper) | ₹336.00 per share | ₹587.00 per share |
Issue Price (Final) | ₹336.00 per share | ₹587.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 44 shares | 25 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹500.00 Cr | up to ₹530.00 Cr |
OFS Issue Size | 5,07,61,000 shares | 55,84,664 shares |
OFS Issue Size (Amount) | up to ₹1,705.57 Cr | up to ₹327.82 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹2,205.57 Cr | up to ₹857.82 Cr |
Global Health IPO opens on Nov 03, 2022, while Kaynes Technology IPO opens on Nov 10, 2022. The closing date of Global Health IPO and Kaynes Technology IPO is Nov 07, 2022, and Nov 14, 2022, respectively.
Global Health IPO | Kaynes Technology IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Nov 03, 2022 | Nov 10, 2022 |
Issue Close | Nov 07, 2022 | Nov 14, 2022 |
Basis Of Allotment (Tentative) | Nov 11, 2022 | Nov 17, 2022 |
Initiation of Refunds (Tentative) | Nov 14, 2022 | Nov 18, 2022 |
Credit of Share (Tentative) | Nov 15, 2022 | Nov 21, 2022 |
Listing date (Tentative) | Nov 16, 2022 | Nov 22, 2022 |
Anchor Lockin End date 1 | Dec 11, 2022 | Dec 17, 2022 |
Anchor Lockin End date 2 | Feb 09, 2023 | Feb 15, 2023 |
Global Health IPO P/E ratio is 38.36, as compared to Kaynes Technology IPO P/E ratio of 84.95.
Global Health IPO | Kaynes Technology IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 35% | 79.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 33% | 67.39% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 38.36 | 84.95 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹9011.01 Cr. | ₹3412.97 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Global Health IPO retail investors (RII) are offered 2,32,52,244 shares while in Kaynes Technology IPO retail investors are offered 2,32,52,244 shares. Qualified institutional buyers (QIB) are offered 1,35,24,905 shares in Global Health IPO and 29,23,888 shares in Kaynes Technology IPO.
Global Health IPO | Kaynes Technology IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 1,35,24,905 shares | 29,23,888 shares |
NII | 99,65,248 shares | 22,55,858 shares |
RII | 2,32,52,244 shares | 52,63,667 shares |
Employee | 0 shares | 26,833 shares |
Others | ||
Total | 4,67,42,397 shares | 1,04,70,246 shares |
Global Health IPO subscribed 9.58x in total, whereas Kaynes Technology IPO subscribed 34.16x.
Global Health IPO | Kaynes Technology IPO | |
---|---|---|
QIB (times) | 28.64x | 98.47x |
NII (times) | 4.02x | 21.21x |
Big NII (times) | 5.16x | 23.07x |
Small NII (times) | 1.73x | 17.47x |
RII (times) | 0.88x | 4.10x |
Employee (times) | 11.92x | |
Other (times) | ||
Total (times) | 9.58x | 34.16x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|